Every step of the way, Rose Booker, formally of the Durham Catholic District School Board, has worked tirelessly to make sure ...

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

In the second quarter, Amgen's product net sales climbed by 20% year over ... If the upcoming results confirm the favorable signs of efficacy and safety, Amgen could be on track to launch its ...

My name is Julianne, and I will be your conference facilitator today for Amgen's third quarter 2024 financial results ...

Speaking on NPR the day after Election Day, Kennedy insisted: “Of course, we’re not going to take vaccines away from anybody, ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious ...

However, you may be eligible for other programs through the manufacturer, such as the Amgen Safety Net Foundation. You can find more information on the program website. You can also see the ...

My name is Julianne, and I will be your conference facilitator today for Amgen's Third Quarter 2024 ... partially offset by lower net selling price of 10%. In the U.S., our expanded primary ...

Located in the heart of Central Ohio’s advanced manufacturing corridor, adjacent to Intel’s $20B Ohio One semiconductor ...

7, 107–109; 2008) — the FDA has been actively recruiting new employees, and CDER achieved a net gain of 396 staff ... Indeed, earlier discussions about safety issues in view of such tools ...